Art. 94 Directive (EU) 2001/83

In forcesince 30 Apr 2004cited 25×
1.

Where medicinal products are being promoted to persons qualified to prescribe or supply them, no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to such persons unless they are inexpensive and relevant to the practice of medicine or pharmacy.

2.

Hospitality at sales promotion events shall always be strictly limited to their main purpose and must not be extended to persons other than health-care professionals.

3.

Persons qualified to prescribe or supply medicinal products shall not solicit or accept any inducement prohibited under paragraph 1 or contrary to paragraph 2.

4.

Existing measures or trade practices in Member States relating to prices, margins and discounts shall not be affected by paragraphs 1, 2 and 3.

The 10 that are cited most themselves, of 25.

  • Judgment of the Court (Fourth Chamber) of 22 April 2010. The Queen, on the application of Association of the British Pharmaceutical IndustryDecisioninterprets

    This reference for a preliminary ruling concerns the interpretation of Article 94(1) of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human …

    22 Apr 2010 · 62009CJ0062

  • Judgment of the Court (Third Chamber) of 11 June 2020. ratiopharm GmbH v Novartis Consumer Health GmbH.Decision

    Title VIIIa of Directive 2001/83, entitled ‘Information and Advertising’, comprises Articles 88a to 100 thereof.

    11 Jun 2020 · 62018CJ0786

  • Judgment of the Court (Third Chamber) of 1 October 2020. A v Daniel B and Others.Decision

    Title VIII, entitled ‘Advertising’, and Title VIIIa, entitled ‘Information and advertising’ of Directive 2001/83 contain, respectively, Articles 86 to 88 and Articles 88a to 100 of that directive.

    1 Oct 2020 · 62018CJ0649

  • BGH, Urteil vom 25. April 2012 - I ZR 105/10Decision

    cc) Bei der Abgabe der Rätselhefte handelt es sich auch nicht um eine Zuwendung von geringem Wert im Sinne von Art. 94 Abs. 1 der Richtlinie 2001/83/EG, so dass eine relevante unsachliche Beeinflussung der Werbeadressaten nicht …

    25 Apr 2012 · KORE311682012

  • BGH, EuGH-Vorlage vom 31. Oktober 2018 - I ZR 235/16Decision

    … Ebenso wie mit dem in Art. 94 Abs. 1 und 3 der Richtlinie 2001/83/EG geregelten Verbot der Vorteilsgewährung sollen mit den in Art. 96 der Richtlinie getroffenen Bestimmungen Verkaufsförderungspraktiken verhindert werden, die geeignet …

    31 Oct 2018 · KORE313212018

  • BGH, Urteil vom 6. Juni 2019 - I ZR 206/17Decision

    (1) Im Schrifttum wird teilweise die Ansicht vertreten, dass das Verbot der Wertwerbung aus Art. 94 Abs. 1 der Richtlinie 2001/83/EG (vormals: Art. 9 Abs. 1 der Richtlinie 92/28/EWG) für die Publikumswerbung entsprechend gilt (vgl. …

    6 Jun 2019 · KORE305152019

  • BGH, Urteil vom 12. Dezember 2013 - I ZR 83/12Decision

    … Das auf der Grundlage des Art. 94 Abs. 1 der Richtlinie 2001/83/EG in § 7 Abs. 1 Satz 1 HWG geregelte grundsätzliche Verbot der Wertreklame soll (nur) solche Verkaufsförderungspraktiken verhindern, die geeignet sind, bei den …

    12 Dec 2013 · KORE303362014

  • Judgment of the Court (Grand Chamber) of 22 December 2022. SIA 'EUROAPTIEKA' v Ministru kabinets.Decision

    Title VIII of that directive, entitled ‘Advertising’, and Title VIIIa thereof, entitled ‘Information and advertising’ contain, respectively, Articles 86 to 88 and Articles 88a to 100 of that directive.

    22 Dec 2022 · 62020CJ0530

  • Opinion of Mr Advocate General Jääskinen delivered on 19 October 2010. Novo Nordisk AS v Ravimiamet.Decision

    Articles 91 to 96 of Directive 2001/83 concern advertising to professionals.

    19 Oct 2010 · 62009CC0249

  • Opinion of Advocate General Szpunar delivered on 9 June 2022. SIA 'EUROAPTIEKA' v Ministru kabinets.Decision

    I delivered an initial Opinion in this case on 9 December 2021, following which the oral part of the procedure was closed.

    9 Jun 2022 · 62020CC0530(01)